InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+15.4%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Siegel Jolie, Directeur Juridique. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 13 disclosures have been published. Activity tracked since 29 July 2021. The latest transaction was disclosed on 13 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
2,135 shares@ US$3.202.8% of flowCommon StockSEC:0001662579-25-000020:0
3,750 sharesCommon StockSEC:0001662579-24-000101:0
2,250 sharesCommon StockSEC:0001662579-24-000079:0
1,735 shares@ US$6.534.5% of flowCommon StockSEC:0001662579-24-000018:0
2,250 sharesCommon StockSEC:0001662579-23-000085:0
20,000 shares0Common StockSEC:0001662579-23-000038:0
3,750 sharesCommon StockSEC:0001662579-23-000019:0
1,102 shares@ US$7.010.0039% mcap3.3% of flowCommon StockSEC:0001209191-22-036718:0
3,750 sharesCommon StockSEC:0001209191-22-032515:0
12,500 shares@ US$4.980.028% mcap24.2% of flowCommon StockSEC:0001209191-21-055881:0
12,500 shares@ US$4.9822.5% of flowCommon StockSEC:0001209191-21-055881
12,500 shares@ US$4.9822.3% of flowCommon StockSEC:0001209191-21-049120
12,500 shares@ US$4.980.028% mcap24.1% of flowCommon StockSEC:0001209191-21-049120:0
13 of 13 declarations
About Siegel Jolie
Jolie Siegel serves as the Chief Legal Officer at C4 Therapeutics, Inc. She oversees the company's legal and regulatory matters, ensuring compliance with applicable laws. Her role is essential in managing legal risks and protecting the company's interests.
